skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)
... > chemical entity > molecular entity > ion > anion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-cer(5-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)
... > chemical entity > molecular entity > ion > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-cer(5-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)
... > chemical entity > molecular entity > polyatomic entity > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-cer(5-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxide > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-cer(5-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)
... > chemical entity > molecular entity > ion > anion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-cer(5-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)
... > chemical entity > molecular entity > ion > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-cer(5-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-cer(5-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)

اصطلاح مرجح

n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(5-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • -5

فرمول

  • C102H163N7O63R

جرم

  • 2495.399

جرم تک‌ایزوتوپی

  • 2493.97662

اسمایلٓ

  • [C@]1(O[C@]([C@@H]([C@H](C1)O)NC(C)=O)([C@@H]([C@H](O[C@]2(O[C@]([C@@H]([C@H](C2)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C(=O)[O-])CO)O)[H])(O[C@H]3[C@H]([C@H](O[C@H]([C@@H]3O)O[C@@H]4[C@H]([C@H](O[C@@H]5[C@H](O[C@]6(O[C@]([C@@H]([C@H](C6)O)NC(C)=O)([C@@H]([C@H](O[C@]7(O[C@]([C@@H]([C@H](C7)O)NC(C)=O)([C@@H]([C@@H](CO)O[C@]8(O[C@]([C@@H]([C@H](C8)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C(=O)[O-])O)[H])C(=O)[O-])CO)O)[H])C([O-])=O)[C@H]([C@H](O[C@@H]9[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]9O)O)CO)O[C@@H]5CO)O)O[C@H](CO)[C@@H]4O)NC(C)=O)CO)O)C([O-])=O

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • alpha-NeuAc-(2->8)-alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-NeuAc-(2->8)-alpha-NeuAc-(2->8)-alpha-NeuAc-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d20:1(4E))(5-)
  • ganglioside GP1c (d20:1(4E))
  • GP1c(d20:1(4E))(5-)
  • N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyleicosasphing-4E-enine(5-)
  • N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyleicosasphingosine(5-)

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141696

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD